MedPath

Proquad

Brand Name: Proquad

Generic Name: Measles, Mumps, Rubella and Varicella Vaccine (Live)

Active
Registration Number

BR-1089

Dosage Form

Lyophilized Powder For Solution For Injection (SC)

Issuance Date

April 1, 2025

Expiry Date

June 9, 2031

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage StrengthEach dose (0.5 mL) contains: Measles virus (Edmonston B) 3.00 log TCID50* Mumps virus (Jeryl Lynn B level)4.30 log TCID50 Rubella virus (Wistar RA 27/3) 3.00 log TCID50 Varicella virus (Oka/Merck) 3.99 PFU** *50% Tissue Culture Infectious Dose **Plaque Forming Units
Packaging3 mL USP/Ph. Eur. Type I glass vial with grey rubber stopper and aluminum flip-off seal (as drug product) 0.7 mL in 1 mL Type I pre-filled needleless glass syringe with black rubber stopper and grey ribbed tip cap (as Sterile Water for Injection) [Box of 1's and 10's].

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Vaccines
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Measles, Mumps, Rubella and Varicella Vaccine (Live)Active
Monograph: measles, mumps, rubella and varicella vaccine (live)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform